High time for new and affordable medicines
Getting innovative medicines to patients more quickly, at a socially acceptable price. That was the aim of the expert meeting ‘Innovation for the benefit of the patient’ being held in Amsterdam on 1 and 2 March.
The Europe Building is the venue where experts will meet to consider the potential and prerequisites for flexible market access with early agreements on the price of innovative medicines.
Bringing together over 100 experts
At the Europe Building in central Amsterdam, Dutch health minister Edith Schippers is hosting a gathering of over 100 experts in pharmaceutical market authorisation, reimbursement and pricing policy. Representatives of the World Health Organization are also attending the conference.
Expensive medication could make care unaffordable
The innovative medicines currently on the market include complex cancer drugs and treatment for small groups of seriously ill people. These drugs improve the patients’ quality of life or cure them completely. The downside is that the treatments are often incredibly expensive and therefore potentially unaffordable. In addition, current regulations require that new medicines be trialled by large groups of patients in order to test their effectiveness. For pharmaceuticals tailored to small patient groups, this is problematic.
Making the system future-proof
The system needs to be made future-proof, not only in the interests of patients, doctors and people who pay insurance premiums, but also of pharmaceutical manufacturers. After all, if their products become unaffordable, it will mean the end of health care. This is why seriously ill patients need access to innovative medicines. In addition, the regulations for authorising these products need to be more flexible and the high prices of pharmaceuticals require scrutiny.
Patient access to innovative medicines
The conference is seeking to answer three questions. First, which products should receive early authorisation? Second, which requirements or standards should they meet? And third, how can we ensure that patients have access to innovative treatments that might not qualify for registration or reimbursement in the current system?
Latest News from
EU clears way for the EU Digital COVID Certificate15/06/2021 09:25:00
The Presidents of the three EU institutions, the European Parliament, the Council of the EU and the European Commission yesterday attended the official signing ceremony for the Regulation on the EU Digital COVID Certificate, marking the end of the legislative process.
Council agrees on new rules for cross-border energy infrastructure14/06/2021 16:48:00
The Council recently (11 June 2021) reached a general approach on the revision of the Trans-European Networks for Energy (TEN-E) Regulation.
Council approves conclusions on an EU renovation wave14/06/2021 15:25:00
The Council recently (11 June 2021) approved conclusions on a renovation wave that repairs the economy now, and creates green buildings for the future.
Council approves EU-UK agreement on fishing opportunities14/06/2021 13:25:00
The Council recently (11 June 2021) approved the agreement between the European Union and the United Kingdom on fishing opportunities for 2021 and, for deep-sea stocks, for 2021 and 2022.
EU-U.S Joint statement on the humanitarian emergency in Tigray14/06/2021 09:25:00
EU-U.S Joint statement given recently (10 June 2021) on the humanitarian emergency in Tigray.
Talent Partnerships: Commission launches new initiative to address EU skills shortages and improve migration cooperation with partner countries11/06/2021 16:33:00
Today, the Commission is launching Talent Partnerships, a key initiative under the New Pact on Migration and Asylum that will help to address skills shortages in the European Union and to strengthen mutually-beneficial partnerships on migration with third countries.
Central America and Mexico: EU reaffirms support with €18.5 million in humanitarian and development aid11/06/2021 15:25:00
The EU yesterday announced at the 'Solidarity event for forcibly displaced persons and host communities in Central America and Mexico', that it will allocate €18.5 million in aid. Of this sum, €12 million represents humanitarian funding to Central America, and €6.5 million constitutes development assistance.
Council endorses new EU strategy on adaptation to climate change11/06/2021 14:38:00
The Council yesterday approved conclusions endorsing a new strategy that outlines a long-term vision for the EU to become a climate-resilient society that is fully adapted to the unavoidable impacts of climate change by 2050.
Child Labour: Statement by the European Commission and the High Representative on the World Day against Child Labour11/06/2021 13:25:00
Child Labour: Statement given by the European Commission and the High Representative on the World Day against Child Labour.
Education: EU increases its commitment to Global Partnership for Education with a pledge of €700 million for 2021-202711/06/2021 12:38:00
Ahead of the G7 Summit, President of the European Commission Ursula von der Leyen yesterday announced that the European Union is pledging €700 million for the Global Partnership for Education (GPE) to help transform education systems for more than one billion girls and boys in up to 90 countries and territories.